Community Pharmacy System Innovation Fund (CPSIF)

Pharmacy X Limited

Based in Blackwood, Gwent. Pharmacy X has received funding of £111,562.50 to support tier 1, 2 and 3 activities.

Titan PMR Limited

Based in Cleve, Bristol. Titan PMR Limited has received funding of £111,562.50 to support tier 1, 2 and 3 activities.

The CPSIF will be open for applications from April 2023 to October 2024. We anticipate that there will be seven closing dates for applications during this time, however, you should check back here for any changes to these. We reserve the right to close applications early should all funding be assigned. There are seven application deadlines:   

• 13 April 2023  

• 6 July 2023  

• 5 October 2023  

• 1 December 2023  

• 4 April 2024  

• 4 July 2024  

• 3 October 2024  

  Applications will close at 12 noon on the dates above. 

Please refer to the Guidance Document for full details of the scope. Projects must aim to:  

• Develop and implement the changes necessary to community pharmacy systems to enable EPS in a Wales-based pharmacy via an assured Patient Medication Record (PMR);    

• Optionally develop and implement changes needed to community pharmacy systems that will result in a paperless prescription journey and/or push notification to the NHS Wales app in a Wales-based pharmacy setting.   

Only activities associated with these aims are within scope of the fund. Full details of the scope of activities associated with each funding tier and the required success criteria are available in the Guidance Document. 

Please note that all projects must meet the scope and eligibility criteria fully detailed in the Guidance Document. You should not begin any work on your project until LSHW confirms in writing that your application has been successful, and work is able to start. Examples of eligible expenditure can be found in the Guidance Document.  

 Applicants must be:   

• UK registered business.    

• Eligible to receive grant funding under the UK’s current subsidy control obligations for Minimal Financial Assistance, de minimis regulations or as a one-off subsidy.   

• Able to demonstrate that they have a UK-based bank account in the name of the applicant organisation.   

• Not in financial difficulties (able to pass due diligence checks on business status, and able to declare that the business and named applicants are not subject to any material litigation).   

• Supplying pharmacies in Wales with an EPS ready patient medication record (PMR) system at the time that success criteria are being assessed and before defrayed payment.   

• Applying for in-scope activities, as a minimum including development of an EPS ready PMR for use in Wales (tier 1 / milestone A).   

• Requesting no more than £55,781 for tier 1 activities, no more than £27,891 for tier 2 activities and no more than £27,891 for tier 3 activities and no more than £111,562.50 overall.    

• Able to confirm that grant funding is needed to ensure the project happens, i.e. the project activity would not progress appropriately without the use of public funds and that the activity represents value for money.    

• Claiming eligible net revenue costs only. Capital expenditure and VAT are ineligible.   

• Able to evidence expenditure on project activities and that required outcomes have been achieved.   

• Able to evidence that any insurance and compliance with legislated requirements are in place.   

• Planning to complete all activities and expenditure by January 31, 2025, with projects fully closed and all costs claimed by March 31, 2025.    

• Able to agree to quarterly monitoring for a minimum of 12 months following the closure of the payment phase to ensure that products remain available to the intended users.   

• Able to agree to sharing of high-level project details and outcomes in the public domain.   

UK-registered businesses who are already supplying community pharmacy systems in Wales or who have the potential to supply these systems, can apply for a CPSIF grant of up to £111,562.50 via a non-competitive funding scheme.

Funding will be provided to eligible organisations, where their application meets the scope and eligibility criteria of the programme, as a defrayed payment of up to 100% eligible project costs at the conclusion of each tier. Applications will be restricted to allow one award only per tier, per registered business. 

Applicants should fully complete the Application Form available for download at the LSHW website and return to fundingsupport@lshubwales.com, with the required supporting information before the closing date of the round to which they intend to apply. 

Applicants must provide their plans for enabling an EPS (tier 1, up to £55,781 available per applicant), and their plans for, or their intention to apply subsequently for optional tiers for enabling a paperless prescription journey (tier 2, up to £27,891 available per applicant) and/or push notification (tier 3, up to £27,891 available per applicant).  The maximum total funding that can be applied for is £111,562.50.

Application forms will collect information including project plans, relevant experience, anticipated costs and subsidy status of the applicant organisation. Applications which meet the scope and eligibility criteria (determined by panel assessment) will be awarded funding.  

If applicants are not able to submit plans for tier 2 and/or 3 in the first application, they will be able to make a subsequent application for these tiers, provided that tier 1 has been applied for. 

All applicants must apply for tier 1 as a minimum, with full applications for tier(s) 2 and/or 3 accepted and assessed following a grant offer letter for tier 1. Applications for tiers 2 and 3 will follow a similar process to that for tier 1. 

We will review applications for compliance and may need to contact you to request further details should any information be omitted from your application form. This may delay the approval of your application. We will conduct due diligence checks on the applicant business including a soft credit check and your last publicly available accounts. 

Should the applicant business appear to be in financial difficulty, it will not be possible to provide funding.  

Once applications have been reviewed, applicants will be provided with a decision letter. This will detail whether we have accepted or declined your application. We may also request additional information from you should the panel be unable to reach a decision based on the information provided by you. Should your application be successful we will contact you to discuss the process of setting up a grant contract, claiming for payments, monitoring, and grant closure.